“ϊ–{ˆγ‰Θ‘εŠwˆγŠw‰οŽGŽ Online Journal ƒƒCƒ“ƒiƒrƒQ[ƒVƒ‡ƒ“‚π”ς‚Ξ‚·
‘–ΪŽŸ > †–ΪŽŸ > Abstract ƒz[ƒ€‚Φ–ί‚ι
Abstract

‘ζ2Šͺ 2006”N4ŒŽ@‘ζ2†

‘S•ΆPDF (1161K)

‘Η—α‚©‚ηŠw‚Τ

ƒRƒŒƒXƒeƒ[ƒ‹Œ‹»ΗπΗiCCEj\ƒXƒeƒƒCƒh—Γ–@‚ΖLDLƒAƒtƒFƒŒ[ƒVƒX•Ή—p‚ΜŒψ‰Κ
‰ͺθ@—εŽq1, ‹e’r@—LŽj1, •½ŽR@‰x”V1, ŠΫŽR@Œυ‹I1, ‚–؁@Œ³1, ‚–μ@mŽi1, ‚ŽR@Žη³1, ¬—с@‹`“T1, ‚–μ@Ζ•v1, ‚“c@‘ε•γ2, ‹ΰŽq@•όL2, ”Ρ–μ@–υ•F2, •ΠŽR@‘Χ˜N2, ŽOΞ@„3, μ–Ό@½Ži3, —tŽR@C—z4
1“ϊ–{ˆγ‰Θ‘εŠw“ΰ‰ΘŠw‘ζˆκ
2“ϊ–{ˆγ‰Θ‘εŠw“ΰ‰ΘŠw‘ζ“ρ
3“ϊ–{ˆγ‰Θ‘εŠw”畆‰ΘŠw
4“ϊ–{ˆγ‰Θ‘εŠwtƒNƒŠƒjƒbƒN

Cholesterol Crystal Embolizm (CCE): Efficacy of a Combined Therapy of LDL Apheresis and Corticosteroid for CCE
Reiko Okazaki1, Arifumi Kikuchi1, Yoshiyuki Hirayama1, Mitsunori Maruyama1, Gen Takagi1, Hitoshi Takano1, Morimasa Takayama1, Yoshinori Kobayashi1, Teruo Takano1, Daisuke Takada2, Tomohiro Kaneko2, Yasuhiko Iino2, Yasuo Katayama2, Tsuyoshi Mitsuishi3, Seiji Kawana3 and Naoaki Hayama4
1The First Department of Internal Medicine, Nippon Medical School
2The Second Department of Internal Medicine, Nippon Medical School
3Department of Dermatology, Nippon Medical School
4Renal Clinic of Nippon Medical School

Cholesterol crystal embolism (CCE) is a systemic disorder caused by microshowers of cholesterol crystals. It brings about decreased microcirculation and is manifested in various organs including the kidneys, skin, brain and extremities. Cholesterol microshowers are thought to occur in about 50% of invasive vascular procedures, but most cases are clinically silent. CCE has a high mortality rate, but there are as yet no established methods for managing it.
We report two cases (63-year-old and 73-year-old males) of progressive renal insufficiency with eosinophilia and peripheral ischemic symptoms such as livedo reticularis and foot pain following percutaneous coronary intervention (PCI) for acute myocardial infarction. In the first case, we made a diagnosis of CCE based on clinical findings, which included deteriorating renal failure after PCI, peripheral eosinophilia, livedo reticularis, smoking history, uncontrollable hypertension, and severe atherosclerotic plaque of the aorta demonstrated by transesophageal echocardiography. In the second case, skin biopsy specimens confirmed a diagnosis of CCE.
In both cases, treatment with prostaglandins and statins was unsatisfactory. However, additional treatment with LDL apheresis (LDL-A) and corticosteroids improved the eosinophillia, livedo reticularis, foot pain and renal function, suggesting that this combined treatment may have a beneficial effect on CCE.

“ϊˆγ‘εˆγ‰οŽ 2006; 2(2), 115-120

Key words
Cholesterol Crystal Embolizm (CCE), corticosteroid, LDL apheresis

Correspondence to
Reiko Okazaki, First Department of Internal Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan
E-mailFOkazaki_Reiko/med1@nms.ac.jp

Žσ•tF2006”N2ŒŽ1“ϊ@Žσ—F2006”N3ŒŽ13“ϊ

ƒƒCƒ“ƒiƒrƒQ[ƒVƒ‡ƒ“‚Φ–ί‚ι ‚±‚Μƒy[ƒW‚Μƒgƒbƒv‚Φ–ί‚ι